<--- Back to Details
First PageDocument Content
Cancer research / Multiple myeloma / Minimal residual disease / International Myeloma Working Group / Stem cells / Lenalidomide / Plasma cell / Bone marrow examination / Thalidomide / Medicine / Hematologic neoplasms / Immunosuppressants
Cancer research
Multiple myeloma
Minimal residual disease
International Myeloma Working Group
Stem cells
Lenalidomide
Plasma cell
Bone marrow examination
Thalidomide
Medicine
Hematologic neoplasms
Immunosuppressants

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 396,29 KB

Share Document on Facebook

Similar Documents

Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects

DocID: 1vorp - View Document

Status of the Self-modulation Experiment at PITZ Outline > Short Introduction > Plasma Cell

DocID: 1uAJX - View Document

Status of plasma cell preparations

DocID: 1uz8K - View Document

Developmental Cell, Vol. 2, 593–605, May, 2002, Copyright 2002 by Cell Press Stt4 PI 4-Kinase Localizes to the Plasma Membrane and Functions in the Pkc1-Mediated MAP Kinase Cascade Anjon Audhya and Scott D. Emr1

DocID: 1u7Um - View Document

PRELIMINARY COMMUNICATION Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection

DocID: 1tT01 - View Document